CardioKinetix Completes $48 Million Series E Round

By Connie Loizos — 3 years ago

CardioKinetix, a Menlo Park, Calif.-based medical device company, has completed the $23 million second-tranche of its Series E financing, bringing the total round to $48 million. Panorama Capital is the company’s newest investor. It joins previous investors U.S. Venture Partners, JPMorgan Partners, New Leaf Venture Partners, SV Life Sciences, H&Q Healthcare Investors, and H&Q Life Sciences Investors.


Veniti Appoints COO

By Angela Sormani — 4 years ago

Veniti, a startup company focused on the treatment of venous disease, has added Scott Solano to its executive team as chief operating officer (COO). Solano joins Veniti with more than 22 years of experience designing, testing and producing medical devices. Veniti raised over $15 million in 2011, led by Baird Venture Partners and H&Q Healthcare […]


CardioKinetix Seals $44M For Medical Devices

4 years ago

CardioKinetix, a medical device company developing transcatheter implants, has raised $44 million in a two-tranche Series E financing. New investors SV Life Sciences and New Leaf Venture Partners led the round, which included return backers including U.S. Venture Partners, J.P. Morgan Partners, H&Q Healthcare Investors and H&Q Life Sciences Investors. The company’s device, dubbed Parachute, is implanted into the left ventricle of the heart in a simple catheter lab procedure and is intended to treat patients with heart failure resulting from a myocardial infarction or heart attack.